Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd

SHPMY

$7.45

Updated: 23/09/2026, 17:04:45

Market Cap
$5.53B
Sector
Healthcare
Industry
Medical - Distribution
Country
CN
Stock valuation chart
One-year closing share-price history for SHPMY
Company Profile

Shanghai Pharmaceuticals Holding Co., Ltd. operates as an investment holding enterprise deeply embedded in China's pharmaceutical and healthcare industries. The company oversees a full range of activities, from the research and development of new drugs to their manufacturing, nationwide distribution, and retail sales of a diverse array of pharmaceutical and health-related products. Its operations are strategically managed across four primary divisions: Production, Distribution, Retail, and Other services. The company's extensive product catalog includes chemical compounds, biochemicals, traditional Chinese remedies, general healthcare items, and medical devices. These offerings are designed to address a broad spectrum of medical conditions, encompassing oncology, cardiovascular and cerebrovascular issues, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory conditions. Notably, their portfolio boasts over 700 distinct pharmaceutical formulations. Beyond product development and manufacturing, Shanghai Pharmaceuticals is a significant player in comprehensive pharmaceutical supply chain management. This involves sophisticated distribution, warehousing, logistics, and various value-added services, all provided to a wide range of clients including drug manufacturers and healthcare providers such as hospitals, other wholesalers, and individual retail pharmacies. Moreover, the company maintains a substantial retail footprint, managing an extensive network of roughly 2,000 chain pharmacies spread across 24 provinces, alongside a thriving online drug commerce platform. Its diverse service offerings further extend to consulting, asset management, facilitating clinical trials, offering medical assistance, educating both medical professionals and patients, handling electronic prescriptions, and pioneering remote and cloud-based hospital solutions. Established in Shanghai in 1994, Shanghai Pharmaceuticals Holding Co., Ltd. functions as a subsidiary under Shanghai Pharmaceutical (Group) Co., Ltd.

USD
OTC
CEO: Qiuhua Yang
Employees: 49,608
https://www.sphchina.com
Asset Summaries
Latest generated summaries for SHPMY

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for SHPMY.
Share price
$7.45
Market cap
$5.53B
Exchange
OTC
Currency
USD
CEO
Qiuhua Yang
Employees
49,608
IPO date
19/02/2014
Beta
0.156
Last dividend
$0.00
Day range
$6.46 – $7.45
52-week range
$6.46 – $8.30
1-day performance
0.00%
1-year performance
15.33%
Current drawdown (1Y)
-10.24%
CIK
N/A
CUSIP
81943R100
ISIN
US81943R1005
Created
07/12/2025, 14:13:25
Last update
23/09/2026, 17:04:45

Track Shanghai Pharmaceuticals Holding Co., Ltd with an AI analyst

See which prediction-market events move SHPMY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to SHPMY from your Railway `news_articles` table.

No news found for this symbol.